Brian Rini

Academic / Other · 1 registered clinical trial — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advan Advanced Renal Cell Carcinoma (aRCC), Metastatic Renal Cell Carcinoma ( mRCC), Clear Cell Renal Cell Carcinoma (ccRCC)	Phase 2	2026-04-01